The demand for clinical research organization (CRO) and conducted clinical trials have been and will keep growing in the upcoming years. This trend is being driven by pharmaceutical, biotech and medical device companies outsourcing these clinical activities to CROs as a result of the increasing size, complexity, duration and costs in clinical trials. With stringent and complex regulatory policies for drug development, the demand for CROs to develop new devices and drugs have become higher than ever. Also spearheading the CRO market is the growth in biosimilars and biologics markets, requirement for specialized testing services and the adoption of advanced technologies in the drug development industry. The growing expenditure in research and development has also been the driving force for the global market of the contract research organization (CRO) industry.

For CROs, drug discovery share is becoming one of the fastest growing segments as contract organizations are crucial in the pharmaceutical sector for drug development in various countries across the globe. As artificial intelligence and machine learning generate great momentum and interest in the pharmaceutical industry, there is a great potential seen from a drug development and clinical trial perspective. AI and ML will bring in increased efficiencies to the statistical analysis and programming of clinical data along with the increasing costs in drug development. Due to a need for experts in therapeutic areas and indications, regulatory requirements and pharmacovigilance, specialists in CRO will be in greater demand.

The current pharma R&D space is being steered by precision-based medicines and immunotherapies for smaller population, genetic led therapies for oncology and rare disease treatment with demanding, complex protocols for drug development. Keeping in mind the current expansions and requirements of the organizations in the pharmaceutical industry, a distinguished panel comprising of CEOs, CIOs, VCs and analysts along with Pharma Tech Outlook’s competent editorial team have put together a list of the prominent CROs in the industry. This edition will give you an outlook on the services and capabilities that they have to offer.

We present to you, Pharma Tech Outlook Magazine’s “Top 10 CROs - 2019.”